Methodology

Phase IV

Post-marketing: pharmacovigilance in real-world use.

Phase IV studies (post-marketing) monitor long-term safety, rare effects, and effectiveness in clinical practice after marketing. May be required by regulators (PASS — post-authorisation safety studies).